Edwards Lifesciences Corporation · NYSE:EW

Lippis Daniel J. sold 1,019 Edwards Lifesciences Corporation shares (Form 4)

Traded Apr 6, 2026 · Filed Apr 6, 2026

On Apr 6, 2026, Lippis Daniel J. (CVP, TAVR) sold 1,019 Edwards Lifesciences Corporation shares at US$80.98 for US$82,519 under a trading plan, leaving 33,934 shares. Filed Apr 6, 2026 (Form 4).

Sold
1,019 shares
Price
US$80.98
Value
US$82,519
Holding after
33,934 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CVP, TAVR

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockOption exercise1,019US$59.2634,953Direct
Apr 6, 2026Common StockSale1,019US$80.9833,934Direct

Source

View original at SEC

Related